Proteomic Analysis of Human Endometrial Tissues Reveals the Roles of PI3K/AKT/mTOR Pathway and Tumor Angiogenesis Molecules in the Pathogenesis of Endometrial Cancer

被引:19
作者
Liu, Zhen [1 ,2 ,3 ]
Hong, Zhipan [4 ]
Qu, Pengpeng [3 ]
机构
[1] Tianjin Med Univ, Dept Obstet & Gynecol, Tianjin 300070, Peoples R China
[2] Inner Mongolia Med Univ, Chifeng Clin Med Sch, Chifeng Municipal Hosp, Dept Gynecol, Chifeng 024000, Peoples R China
[3] Tianjin Cent Hosp Gynecol & Obstet, Dept Gynecol Oncol, Tianjin 300070, Peoples R China
[4] Inner Mongolia Med Univ, Chifeng Municipal Hosp, Dept Tumor Surg, Chifeng Clin Med Sch, Chifeng 024000, Peoples R China
关键词
ENDOTHELIAL GROWTH-FACTOR; EXPRESSION; OSTEOPONTIN; ENVIRONMENT; PROTEINS; CATENIN; PI3K;
D O I
10.1155/2020/5273969
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
As one major gynecological malignancy, endometrial cancer (EC) has been widely studied recently. However, its pathogenesis is still unclear to date. In this study, we identified differentially expressed proteins between 30 endometrial cancer tissues and 30 matched normal controls using 2D LC-MS/MS quantitative proteomics. As a result, we identified 619 differentially expressed proteins among all 2521 proteins being quantified. Further analyses suggested that the changes of fat, amino acid metabolism, peroxisome, extracellular signal, cytoskeleton, and other signaling or metabolic pathways may be closely related to the development of this cancer. Particularly, the PI3K/AKT/mTOR pathway-related molecules including PI3K and mTOR, ERK (the molecule of the ERK pathway), SPP1, and ANGPT2 (angiogenesis-related molecules) are highly associated with the pathogenesis of EC, which were reconfirmed by western blot and immunohistochemistry (IHC) analysis. In summary, our study revealed that the PI3K/AKT/mTOR pathway and tumor angiogenesis molecules contribute to the pathogenesis of endometrial cancer.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] ANALYSIS OF PI3K/AKT/mTOR SIGNALLING PATHWAY IN HIGH RISK NEUROBLASTIC TUMOURS
    Izycka-Swieszewska, Ewa
    Drozynska, Elzbieta
    Rzepko, Robert
    Kobierska-Gulida, Grazyna
    Grajkowska, Wieslawa
    Perek, Danuta
    Balcerska, Anna
    POLISH JOURNAL OF PATHOLOGY, 2010, 61 (04) : 192 - 198
  • [32] ESM1 promotes angiogenesis in colorectal cancer by activating PI3K/Akt/mTOR pathway, thus accelerating tumor progression
    Yang, Liqun
    Dong, Zhigang
    Li, Shuyu
    Chen, Tieliang
    AGING-US, 2023, 15 (08): : 2920 - 2936
  • [33] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    Li, HaiXia
    Zeng, JianFang
    Shen, Keng
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (06) : 1067 - 1078
  • [34] Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
    Roudsari, Nazanin Momeni
    Lashgari, Naser-Aldin
    Momtaz, Saeideh
    Abaft, Shaghayegh
    Jamali, Fatemeh
    Safaiepour, Pardis
    Narimisa, Kiyana
    Jackson, Gloria
    Bishayee, Anusha
    Rezaei, Nima
    Abdolghaffari, Amir Hossein
    Bishayee, Anupam
    PHARMACEUTICS, 2021, 13 (08)
  • [35] PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
    Leiphrakpam, Premila D.
    Are, Chandrakanth
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [36] Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer
    Akbarzadeh, Maryam
    Mihanfar, Ainaz
    Akbarzadeh, Shabnam
    Yousefi, Bahman
    Majidinia, Maryam
    LIFE SCIENCES, 2021, 285
  • [37] PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
    Wu, P.
    Hu, Y-Z
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (35) : 4326 - 4341
  • [38] PTEN regulate angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells
    Ma, Jiachi
    Sawai, Hirozumi
    Ochi, Nobuo
    Matsuo, Yoichi
    Xu, Donghui
    Yasuda, Akira
    Takahashi, Hiroki
    Wakasugi, Takehiro
    Takeyama, Hiromitsu
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2009, 331 (1-2) : 161 - 171
  • [39] PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
    Glaviano, Antonino
    Foo, Aaron S. C.
    Lam, Hiu Y.
    Yap, Kenneth C. H.
    Jacot, William
    Jones, Robert H.
    Eng, Huiyan
    Nair, Madhumathy G.
    Makvandi, Pooyan
    Geoerger, Birgit
    Kulke, Matthew H.
    Baird, Richard D.
    Prabhu, Jyothi S.
    Carbone, Daniela
    Pecoraro, Camilla
    Teh, Daniel B. L.
    Sethi, Gautam
    Cavalieri, Vincenzo
    Lin, Kevin H.
    Javidi-Sharifi, Nathalie R.
    Toska, Eneda
    Davids, Matthew S.
    Brown, Jennifer R.
    Diana, Patrizia
    Stebbing, Justin
    Fruman, David A.
    Kumar, Alan P.
    MOLECULAR CANCER, 2023, 22 (01)
  • [40] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    HaiXia Li
    JianFang Zeng
    Keng Shen
    Archives of Gynecology and Obstetrics, 2014, 290 : 1067 - 1078